Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Outlook 2036
The global Hypertrophic Cardiomyopathy (HCM) Therapeutics Market is steadily evolving as awareness, early diagnosis, and targeted treatment approaches reshape the management of this complex genetic heart disorder. Hypertrophic cardiomyopathy, characterized by abnormal thickening of the heart muscle, can lead to heart failure, arrhythmias, and sudden cardiac death if left untreated. With medical science advancing rapidly, the therapeutic landscape for HCM is entering a new phase of precision-driven care.